Form 20-F ☑
|
Form 40-F ☐
|
Yes ☐
|
No ☑
|
EXFO INC.
|
|
By: /s/ Germain Lamonde
Name: Germain Lamonde
Title: President and Chief Executive Officer
|
|
§
|
Sales increase 5.1% year-over-year to US$53.6 million
|
§
|
Bookings improve 9.2% year-over-year to US$59.7 million, book-to-bill ratio of 1.11
|
§
|
Gross margin reaches 64.7%, highest level in four years
|
§
|
Adjusted EBITDA totals US$5.3 million, 9.9% of sales
|
Q2 2016
|
Q1 2016
|
Q2 2015
|
||||||||||
Physical-layer sales
|
$
|
32,582
|
$
|
37,477
|
$
|
33,059
|
||||||
Protocol-layer sales
|
21,990
|
18,629
|
18,531
|
|||||||||
Foreign exchange losses on forward exchange contracts
|
(975
|
)
|
(874
|
)
|
(600
|
)
|
||||||
Total sales
|
$
|
53,597
|
$
|
55,232
|
$
|
50,990
|
||||||
Physical-layer bookings
|
$
|
34,873
|
$
|
38,878
|
$
|
33,223
|
||||||
Protocol-layer bookings
|
25,805
|
20,469
|
22,027
|
|||||||||
Foreign exchange losses on forward exchange contracts
|
(975
|
)
|
(874
|
)
|
(600
|
)
|
||||||
Total bookings
|
$
|
59,703
|
$
|
58,473
|
$
|
54,650
|
||||||
Book-to-bill ratio
|
1.11
|
1.06
|
1.07
|
|||||||||
Gross margin*
|
$
|
34,693
|
$
|
35,095
|
$
|
31,444
|
||||||
64.7%
|
|
63.5%
|
|
61.7%
|
|
|||||||
Other selected information:
|
||||||||||||
IFRS net earnings
|
$
|
3,963
|
$
|
1,766
|
$
|
931
|
||||||
Amortization of intangible assets
|
$
|
286
|
$
|
300
|
$
|
1,019
|
||||||
Stock-based compensation costs
|
$
|
314
|
$
|
376
|
$
|
388
|
||||||
Net income tax effect of the above items
|
$
|
(30
|
)
|
$
|
(28
|
)
|
$
|
(53
|
)
|
|||
Foreign exchange gain
|
$
|
1,101
|
$
|
310
|
$
|
2,987
|
||||||
Adjusted EBITDA*
|
$
|
5,280
|
$
|
5,286
|
$
|
1,158
|
·
|
Bookings and Sales. Bookings increased 9.2% year-over-year (or approximately 12% on a constant currency basis*) to US$59.7 million in the second quarter of 2016, while sales increased 5.1% (or approximately 8% on a constant currency basis) to US$53.6 million. EXFO's book-to bill ratio reached 1.11 in the second quarter and 1.09 in the first half of fiscal 2016. Bookings were particularly robust within the company's Protocol product line, including 100G optical transport solutions and analytics software. From a geographic standpoint, 49% of sales originated from the Americas, 29% from EMEA and 22% from Asia-Pacific. EXFO's top customer accounted for 6.8% of sales, while the top three represented 13.3%.
|
·
|
Profitability. Adjusted EBITDA increased more than 350% year-over-year to US$5.3 million in the second quarter of 2016. At the halfway mark of fiscal 2016, EXFO delivered US$10.6 million in adjusted EBITDA, up 143% year-over-year, placing the company in a good position with regard to its US$20 million annual target. EXFO generated US$15.3 million in cash flows from operating activities in the second quarter of 2016 and US$18.6 million in the first half of the fiscal year.
|
·
|
Innovation. EXFO launched five new solutions during the second quarter of 2016 including TestFlow, a revolutionary, cloud-based field test automation solution that allows network operators to automate complex, labor-intensive activities like fiber-to-the antenna (FTTA), distributed antenna system (DAS) and small cell deployments. The company also introduced a whole new family of optical time domain reflectometers (OTDRs), a segment in which it owns 48% of global market share, establishing new industry standards for specifications and time savings in characterizing optical networks. Other new product introductions consist of solutions for data center and enterprise network testing; an industry-first, high-resolution, wavelength-tunable OTDR for single-ended network troubleshooting; and the telecom industry's first G.fast handheld test set for the roll out of ultra-broadband services on copper links. Following the quarter-end, EXFO unveiled its new test strategy and platform for the lab market at the Optical Fiber Conference (OFC) in Anaheim.
|
Q2 2016
|
Q1 2016
|
Q2 2015
|
||||||||||
IFRS net earnings for the period
|
$
|
3,963
|
$
|
1,766
|
$
|
931
|
||||||
Add (deduct):
|
||||||||||||
Depreciation of property, plant and equipment
|
924
|
975
|
1,256
|
|||||||||
Amortization of intangible assets
|
286
|
300
|
1,019
|
|||||||||
Interest and other (income) expenses
|
(470
|
)
|
63
|
(35
|
)
|
|||||||
Income taxes
|
1,364
|
2,116
|
586
|
|||||||||
Stock-based compensation costs
|
314
|
376
|
388
|
|||||||||
Foreign exchange gain
|
(1,101
|
)
|
(310
|
)
|
(2,987
|
)
|
||||||
Adjusted EBITDA for the period
|
$
|
5,280
|
$
|
5,286
|
$
|
1,158
|
||||||
Adjusted EBITDA in percentage of sales
|
9.9%
|
|
9.6%
|
|
2.3%
|
|
As at
February 29,
2016
|
As at
August 31,
2015
|
|||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash
|
$
|
43,418
|
$
|
25,864
|
||||
Short-term investments
|
958
|
1,487
|
||||||
Accounts receivable
|
||||||||
Trade
|
37,289
|
48,068
|
||||||
Other
|
2,213
|
2,384
|
||||||
Income taxes and tax credits recoverable
|
3,215
|
3,855
|
||||||
Inventories
|
33,088
|
27,951
|
||||||
Prepaid expenses
|
2,693
|
2,801
|
||||||
122,874
|
112,410
|
|||||||
Tax credits recoverable
|
34,103
|
35,625
|
||||||
Property, plant and equipment
|
34,937
|
35,695
|
||||||
Intangible assets
|
3,626
|
4,096
|
||||||
Goodwill
|
21,255
|
21,860
|
||||||
Deferred income tax assets
|
8,300
|
8,900
|
||||||
Other assets
|
433
|
416
|
||||||
$
|
225,528
|
$
|
219,002
|
|||||
Liabilities
|
||||||||
Current liabilities
|
||||||||
Bank loan
|
$
|
457
|
$
|
–
|
||||
Accounts payable and accrued liabilities
|
34,314
|
34,126
|
||||||
Provisions
|
308
|
427
|
||||||
Income taxes payable
|
654
|
779
|
||||||
Deferred revenue
|
9,326
|
7,647
|
||||||
45,059
|
42,979
|
|||||||
Deferred revenue
|
4,684
|
2,957
|
||||||
Deferred income tax liabilities
|
1,977
|
1,524
|
||||||
Other liabilities
|
440
|
791
|
||||||
52,160
|
48,251
|
|||||||
Shareholders' equity
|
||||||||
Share capital (note 5)
|
87,031
|
86,045
|
||||||
Contributed surplus
|
17,286
|
17,778
|
||||||
Retained earnings
|
124,662
|
118,933
|
||||||
Accumulated other comprehensive loss
|
(55,611
|
)
|
(52,005
|
)
|
||||
173,368
|
170,751
|
|||||||
$
|
225,528
|
$
|
219,002
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Sales
|
$
|
53,597
|
$
|
108,829
|
$
|
50,990
|
$
|
107,714
|
||||||||
Cost of sales (1) (note 6)
|
18,904
|
39,041
|
19,546
|
40,783
|
||||||||||||
Selling and administrative (note 6)
|
19,565
|
39,817
|
20,168
|
41,200
|
||||||||||||
Net research and development (note 6)
|
10,162
|
20,095
|
10,506
|
22,164
|
||||||||||||
Depreciation of property, plant and equipment (note 6)
|
924
|
1,899
|
1,256
|
2,501
|
||||||||||||
Amortization of intangible assets (note 6)
|
286
|
586
|
1,019
|
2,117
|
||||||||||||
Interest and other income
|
(470
|
)
|
(407
|
)
|
(35
|
)
|
(252
|
)
|
||||||||
Foreign exchange gain
|
(1,101
|
)
|
(1,411
|
)
|
(2,987
|
)
|
(4,962
|
)
|
||||||||
Earnings before income taxes
|
5,327
|
9,209
|
1,517
|
4,163
|
||||||||||||
Income taxes (note 7)
|
1,364
|
3,480
|
586
|
1,751
|
||||||||||||
Net earnings for the period
|
$
|
3,963
|
$
|
5,729
|
$
|
931
|
$
|
2,412
|
||||||||
Basic net earnings per share
|
$
|
0.07
|
$
|
0.11
|
$
|
0.02
|
$
|
0.04
|
||||||||
Diluted net earnings per share
|
$
|
0.07
|
$
|
0.10
|
$
|
0.02
|
$
|
0.04
|
||||||||
Basic weighted average number of shares outstanding (000's)
|
53,927
|
53,870
|
59,216
|
59,775
|
||||||||||||
Diluted weighted average number of shares outstanding (000's) (note 8)
|
54,615
|
54,575
|
59,813
|
60,396
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Net earnings for the period
|
$
|
3,963
|
$
|
5,729
|
$
|
931
|
$
|
2,412
|
||||||||
Other comprehensive income (loss), net of income taxes
|
||||||||||||||||
Items that will not be reclassified subsequently to net earnings
|
||||||||||||||||
Foreign currency translation adjustment
|
(2,204
|
)
|
(4,713
|
)
|
(18,566
|
)
|
(30,301
|
)
|
||||||||
Items that may be reclassified subsequently to net earnings
|
||||||||||||||||
Unrealized losses on forward exchange contracts
|
50
|
(220
|
)
|
(2,697
|
)
|
(4,202
|
)
|
|||||||||
Reclassification of realized losses on forward exchange contracts in net earnings
|
839
|
1,717
|
338
|
500
|
||||||||||||
Deferred income tax effect of losses on forward exchange contracts
|
(242
|
)
|
(390
|
)
|
622
|
995
|
||||||||||
Other comprehensive loss
|
(1,557
|
)
|
(3,606
|
)
|
(20,303
|
)
|
(33,008
|
)
|
||||||||
Comprehensive income (loss) for the period
|
$
|
2,406
|
$
|
2,123
|
$
|
(19,372
|
)
|
$
|
(30,596
|
)
|
Six months ended February 28, 2015
|
||||||||||||||||||||
Share
capital
|
Contributed surplus
|
Retained earnings
|
Accumulated other comprehensive loss
|
Total
shareholders' equity
|
||||||||||||||||
Balance as at September 1, 2014
|
$
|
111,491
|
$
|
16,503
|
$
|
113,635
|
$
|
(10,259
|
)
|
$
|
231,370
|
|||||||||
Redemption of share capital (note 5)
|
(26,314
|
)
|
1,211
|
–
|
–
|
(25,103
|
)
|
|||||||||||||
Reclassification of stock-based compensation costs (note 5)
|
1,350
|
(1,350
|
)
|
–
|
–
|
–
|
||||||||||||||
Stock-based compensation costs
|
–
|
789
|
–
|
–
|
789
|
|||||||||||||||
Net earnings for the period
|
–
|
–
|
2,412
|
–
|
2,412
|
|||||||||||||||
Other comprehensive loss
|
||||||||||||||||||||
Foreign currency translation adjustment
|
–
|
–
|
–
|
(30,301
|
)
|
(30,301
|
)
|
|||||||||||||
Changes in unrealized losses on forward exchange contracts, net of deferred income taxes of $995
|
–
|
–
|
–
|
(2,707
|
)
|
(2,707
|
)
|
|||||||||||||
Total comprehensive loss for the period
|
(30,596
|
)
|
||||||||||||||||||
Balance as at February 28, 2015
|
$
|
86,527
|
$
|
17,153
|
$
|
116,047
|
$
|
(43,267
|
)
|
$
|
176,460
|
Six months ended February 29, 2016
|
||||||||||||||||||||
Share
capital
|
Contributed surplus
|
Retained earnings
|
Accumulated other comprehensive loss
|
Total
shareholders' equity
|
||||||||||||||||
Balance as at September 1, 2015
|
$
|
86,045
|
$
|
17,778
|
$
|
118,933
|
$
|
(52,005
|
)
|
$
|
170,751
|
|||||||||
Redemption of share capital (note 5)
|
(244
|
)
|
57
|
–
|
–
|
(187
|
)
|
|||||||||||||
Reclassification of stock-based compensation costs (note 5)
|
1,230
|
(1,230
|
)
|
–
|
–
|
–
|
||||||||||||||
Stock-based compensation costs
|
–
|
681
|
–
|
–
|
681
|
|||||||||||||||
Net earnings for the period
|
–
|
–
|
5,729
|
–
|
5,729
|
|||||||||||||||
Other comprehensive income (loss)
|
||||||||||||||||||||
Foreign currency translation adjustment
|
–
|
–
|
–
|
(4,713
|
)
|
(4,713
|
)
|
|||||||||||||
Changes in unrealized losses on forward exchange contracts, net of deferred income taxes of $390
|
–
|
–
|
–
|
1,107
|
1,107
|
|||||||||||||||
Total comprehensive income for the period
|
2,123
|
|||||||||||||||||||
Balance as at February 29, 2016
|
$
|
87,031
|
$
|
17,286
|
$
|
124,662
|
$
|
(55,611
|
)
|
$
|
173,368
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Cash flows from operating activities
|
||||||||||||||||
Net earnings for the period
|
$
|
3,963
|
$
|
5,729
|
$
|
931
|
$
|
2,412
|
||||||||
Add (deduct) items not affecting cash
|
||||||||||||||||
Stock-based compensation costs
|
314
|
690
|
388
|
788
|
||||||||||||
Depreciation and amortization
|
1,210
|
2,485
|
2,275
|
4,618
|
||||||||||||
Deferred revenue
|
2,162
|
3,673
|
1,531
|
504
|
||||||||||||
Deferred income taxes
|
101
|
674
|
(11
|
)
|
(343
|
)
|
||||||||||
Changes in foreign exchange gain/loss
|
(615
|
)
|
(959
|
)
|
(1,770
|
)
|
(2,798
|
)
|
||||||||
7,135
|
12,292
|
3,344
|
5,181
|
|||||||||||||
Changes in non-cash operating items
|
||||||||||||||||
Accounts receivable
|
11,305
|
9,281
|
3,719
|
(1,317
|
)
|
|||||||||||
Income taxes and tax credits
|
1,211
|
933
|
(1,211
|
)
|
(1,423
|
)
|
||||||||||
Inventories
|
(2,642
|
)
|
(5,868
|
)
|
(752
|
)
|
(1,933
|
)
|
||||||||
Prepaid expenses
|
(20
|
)
|
34
|
(165
|
)
|
(501
|
)
|
|||||||||
Other assets
|
10
|
203
|
(2
|
)
|
(1
|
)
|
||||||||||
Accounts payable, accrued liabilities and provisions
|
(1,644
|
)
|
1,731
|
824
|
7,660
|
|||||||||||
Other liabilities
|
(26
|
)
|
(54
|
)
|
(13
|
)
|
(32
|
)
|
||||||||
15,329
|
18,552
|
5,744
|
7,634
|
|||||||||||||
Cash flows from investing activities
|
||||||||||||||||
Additions to short-term investments
|
‒
|
(21
|
)
|
(5,818
|
)
|
(19,509
|
)
|
|||||||||
Proceeds from disposal and maturity of short-term investments
|
501
|
501
|
8,300
|
22,066
|
||||||||||||
Purchases capital assets
|
(927
|
)
|
(2,236
|
)
|
(2,045
|
)
|
(2,799
|
)
|
||||||||
(426
|
)
|
(1,756
|
)
|
437
|
(242
|
)
|
||||||||||
Cash flows from financing activities
|
||||||||||||||||
Bank loan
|
153
|
468
|
‒
|
‒
|
||||||||||||
Redemption of share capital (note 5)
|
(186
|
)
|
(187
|
)
|
(24,250
|
)
|
(25,103
|
)
|
||||||||
(33
|
)
|
281
|
(24,250
|
)
|
(25,103
|
)
|
||||||||||
Effect of foreign exchange rate changes on cash
|
674
|
477
|
(3,795
|
)
|
(6,053
|
)
|
||||||||||
Change in cash
|
15,544
|
17,554
|
(21,864
|
)
|
(23,764
|
)
|
||||||||||
Cash – Beginning of the period
|
27,874
|
25,864
|
52,221
|
54,121
|
||||||||||||
Cash – End of the period
|
$
|
43,418
|
$
|
43,418
|
$
|
30,357
|
$
|
30,357
|
||||||||
Supplementary information
|
||||||||||||||||
Income taxes paid
|
$
|
508
|
$
|
1,116
|
$
|
457
|
$
|
824
|
||||||||
Additions to capital assets
|
$
|
1,066
|
$
|
2,375
|
$
|
2,048
|
$
|
2,938
|
1
|
Nature of Activities and Incorporation
|
2
|
Basis of Presentation
|
3
|
Restructuring Charges
|
4
|
Financial Instruments
|
Level 1: | Quoted prices (unadjusted) in active market for identical assets or liabilities; |
Level 2: | Inputs other than quoted prices included within Level 1 that are observable for the asset and liability, either directly or indirectly; |
Level 3: | Unobservable inputs for the asset or liability. |
As at February 29, 2016
|
As at August 31, 2015
|
|||||||||||||||
Level 1
|
Level 2
|
Level 1
|
Level 2
|
|||||||||||||
Financial assets
|
||||||||||||||||
Short-term investments
|
$
|
958
|
$
|
–
|
$
|
1,487
|
$
|
–
|
||||||||
Forward exchange contracts
|
$
|
–
|
$
|
405
|
$
|
–
|
$
|
–
|
||||||||
Financial Liabilities
|
||||||||||||||||
Forward exchange contracts
|
$
|
–
|
$
|
2,942
|
$
|
–
|
$
|
4,154
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual forward rates
|
|||||||
March 2016 to August 2016
|
$
|
12,600
|
1.1976
|
||||||
September 2016 to August 2017
|
19,800
|
1.2779
|
|||||||
September 2017 to August 2018
|
9,300
|
1.3402
|
|||||||
September 2018 to December 2018
|
1,900
|
1.3639
|
|||||||
Total
|
$
|
43,600
|
1.2717
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual forward rates
|
|||||||
March 2016 to August 2016
|
$
|
3,100
|
67.92
|
||||||
September 2016 to February 2017
|
1,400
|
71.12
|
|||||||
Total
|
$
|
4,500
|
68.91
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Losses on forward exchange contracts
|
$
|
975
|
$
|
1,849
|
$
|
600
|
$
|
892
|
5
|
Share Capital
|
Six months ended February 28, 2015
|
||||||||||||||||||||
Multiple voting shares
|
Subordinate voting shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
Amount
|
||||||||||||||||
Balance as at September 1, 2014
|
31,643,000
|
$
|
1
|
28,703,750
|
$
|
111,490
|
$
|
111,491
|
||||||||||||
Redemption of restricted share units
|
−
|
−
|
115,669
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(236,486
|
)
|
(919
|
)
|
(919
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
−
|
−
|
−
|
443
|
443
|
|||||||||||||||
Balance as at November 30, 2014
|
31,643,000
|
1
|
28,582,933
|
111,014
|
111,015
|
|||||||||||||||
Redemption of restricted share units
|
−
|
−
|
107,099
|
−
|
−
|
|||||||||||||||
Redemption of deferred share units
|
−
|
−
|
48,697
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(6,521,739
|
)
|
(25,395
|
)
|
(25,395
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
–
|
–
|
–
|
907
|
907
|
|||||||||||||||
Balance as at February 28, 2015
|
31,643,000
|
$
|
1
|
22,216,990
|
$
|
86,526
|
$
|
86,527
|
Six months ended February 29, 2016
|
||||||||||||||||||||
Multiple voting shares
|
Subordinate voting shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
amount
|
||||||||||||||||
Balance as at September 1, 2015
|
31,643,000
|
$
|
1
|
22,092,034
|
$
|
86,044
|
$
|
86,045
|
||||||||||||
Redemption of restricted share units
|
−
|
−
|
155,784
|
−
|
−
|
|||||||||||||||
Redemption of deferred share units
|
−
|
−
|
653
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(200
|
)
|
(1
|
)
|
(1
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
−
|
−
|
−
|
723
|
723
|
|||||||||||||||
Balance as at November 30, 2015
|
31,643,000
|
1
|
22,248,271
|
86,766
|
86,767
|
|||||||||||||||
Redemption of restricted share units
|
−
|
−
|
119,973
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(62,442
|
)
|
(243
|
)
|
(243
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
−
|
−
|
−
|
507
|
507
|
|||||||||||||||
Balance as at February 29, 2016
|
31,643,000
|
$
|
1
|
22,305,802
|
$
|
87,030
|
$
|
87,031
|
6
|
Statements of Earnings
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Gross research and development expenses
|
$
|
11,472
|
$
|
22,751
|
$
|
12,176
|
$
|
25,485
|
||||||||
Research and development tax credits and grants
|
(1,310
|
)
|
(2,656
|
)
|
(1,670
|
)
|
(3,321
|
)
|
||||||||
Net research and development expenses for the period
|
$
|
10,162
|
$
|
20,095
|
$
|
10,506
|
$
|
22,164
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Inventory write-down for the period
|
$
|
609
|
$
|
1,456
|
$
|
1,046
|
$
|
1,979
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Cost of sales
|
||||||||||||||||
Depreciation of property, plant and equipment
|
$
|
312
|
$
|
635
|
$
|
374
|
$
|
769
|
||||||||
Amortization of intangible assets
|
168
|
345
|
441
|
1,112
|
||||||||||||
480
|
980
|
815
|
1,881
|
|||||||||||||
Selling and administrative expenses
|
||||||||||||||||
Depreciation of property, plant and equipment
|
114
|
260
|
135
|
277
|
||||||||||||
Amortization of intangible assets
|
18
|
36
|
338
|
702
|
||||||||||||
132
|
296
|
473
|
979
|
|||||||||||||
Net research and development expenses
|
||||||||||||||||
Depreciation of property, plant and equipment
|
498
|
1,004
|
747
|
1,455
|
||||||||||||
Amortization of intangible assets
|
100
|
205
|
240
|
303
|
||||||||||||
598
|
1,209
|
987
|
1,758
|
|||||||||||||
$
|
1,210
|
$
|
2,485
|
$
|
2,275
|
$
|
4,618
|
|||||||||
Depreciation of property, plant and equipment
|
$
|
924
|
$
|
1,899
|
$
|
1,256
|
$
|
2,501
|
||||||||
Amortization of intangible assets
|
286
|
586
|
1,019
|
2,117
|
||||||||||||
Total depreciation and amortization expenses for the period
|
$
|
1,210
|
$
|
2,485
|
$
|
2,275
|
$
|
4,618
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Salaries and benefits
|
$
|
27,794
|
$
|
54,758
|
$
|
29,097
|
$
|
59,307
|
||||||||
Stock-based compensation costs
|
314
|
690
|
388
|
788
|
||||||||||||
Total employee compensation for the period
|
$
|
28,108
|
$
|
55,448
|
$
|
29,485
|
$
|
60,095
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Cost of sales
|
$
|
24
|
$
|
55
|
$
|
38
|
$
|
83
|
||||||||
Selling and administrative expenses
|
224
|
490
|
260
|
523
|
||||||||||||
Net research and development expenses
|
66
|
145
|
90
|
182
|
||||||||||||
Total stock-based compensation for the period
|
$
|
314
|
$
|
690
|
$
|
388
|
$
|
788
|
7
|
Income Taxes
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Income tax provision (recovery) at combined Canadian federal and provincial statutory tax rate (27%)
|
$
|
1,438
|
$
|
2,486
|
$
|
410
|
$
|
1,124
|
||||||||
Increase (decrease) due to:
|
||||||||||||||||
Foreign income taxed at different rates
|
(242
|
)
|
(400
|
)
|
582
|
577
|
||||||||||
Non-taxable (income)/loss
|
(274
|
)
|
(70
|
)
|
243
|
1,074
|
||||||||||
Non-deductible expenses
|
145
|
315
|
172
|
374
|
||||||||||||
Foreign exchange effect of translation of foreign subsidiaries in the functional currency
|
251
|
101
|
(2,126
|
)
|
(3,119
|
)
|
||||||||||
Utilization of previously unrecognized deferred income tax assets
|
(32
|
)
|
(32
|
)
|
(80
|
)
|
(80
|
)
|
||||||||
Unrecognized deferred income tax assets on temporary deductible differences and unused tax losses
|
330
|
1,342
|
1,379
|
1,983
|
||||||||||||
Other
|
(252
|
)
|
(262
|
)
|
6
|
(182
|
)
|
|||||||||
Income tax provision for the period
|
$
|
1,364
|
$
|
3,480
|
$
|
586
|
$
|
1,751
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Current
|
$
|
1,263
|
$
|
2,806
|
$
|
597
|
$
|
2,094
|
||||||||
Deferred
|
101
|
674
|
(11
|
)
|
(343
|
)
|
||||||||||
$
|
1,364
|
$
|
3,480
|
$
|
586
|
$
|
1,751
|
8
|
Earnings per Share
|
Three months
ended
February 29,
2016
|
Six months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 28,
2015
|
|||||||||||||
Basic weighted average number of shares outstanding (000's)
|
53,927
|
53,870
|
59,216
|
59,775
|
||||||||||||
Plus dilutive effect of (000's):
|
||||||||||||||||
Restricted share units
|
563
|
585
|
492
|
510
|
||||||||||||
Deferred share units
|
125
|
120
|
105
|
111
|
||||||||||||
Diluted weighted average number of shares outstanding (000's)
|
54,615
|
54,575
|
59,813
|
60,396
|
||||||||||||
Stock awards excluded from the calculation of diluted weighted average number of shares because their exercise price was greater than the average market price of the common shares (000's)
|
244
|
152
|
67
|
88
|
Three months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 29,
2016
|
Six months
ended
February 28,
2015
|
|||||||||||||
Sales
|
$
|
53,597
|
$
|
50,990
|
$
|
108,829
|
$
|
107,714
|
||||||||
Cost of sales (1)
|
18,904
|
19,546
|
39,041
|
40,783
|
||||||||||||
Selling and administrative
|
19,565
|
20,168
|
39,817
|
41,200
|
||||||||||||
Net research and development
|
10,162
|
10,506
|
20,095
|
22,164
|
||||||||||||
Depreciation of property, plant and equipment
|
924
|
1,256
|
1,899
|
2,501
|
||||||||||||
Amortization of intangible assets
|
286
|
1,019
|
586
|
2,117
|
||||||||||||
Interest and other income
|
(470
|
)
|
(35
|
)
|
(407
|
)
|
(252
|
)
|
||||||||
Foreign exchange gain
|
(1,101
|
)
|
(2,987
|
)
|
(1,411
|
)
|
(4,962
|
)
|
||||||||
9,209
|
||||||||||||||||
Earnings before income taxes
|
5,327
|
1,517
|
4,163
|
|||||||||||||
Income taxes
|
1,364
|
586
|
3,480
|
1,751
|
||||||||||||
Net earnings for the period
|
$
|
3,963
|
$
|
931
|
$
|
5,729
|
$
|
2,412
|
||||||||
Basic net earnings per share
|
$
|
0.07
|
$
|
0.02
|
$
|
0.11
|
$
|
0.04
|
||||||||
Diluted net earnings per share
|
$
|
0.07
|
$
|
0.02
|
$
|
0.10
|
$
|
0.04
|
||||||||
Other selected information:
|
||||||||||||||||
Gross margin before depreciation and amortization (2)
|
$
|
34,693
|
$
|
31,444
|
$
|
69,788
|
$
|
66,931
|
||||||||
Research and development:
|
||||||||||||||||
Gross research and development
|
$
|
11,472
|
$
|
12,176
|
$
|
22,751
|
$
|
25,485
|
||||||||
Net research and development
|
$
|
10,162
|
$
|
10,506
|
$
|
20,095
|
$
|
22,164
|
||||||||
Adjusted EBITDA (2)
|
$
|
5,280
|
$
|
1,158
|
$
|
10,566
|
$
|
4,355
|
(1)
|
The cost of sales is exclusive of depreciation and amortization, shown separately.
|
(2)
|
Refer to page 34 for non-IFRS measures.
|
Three months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 29,
2016
|
Six months
ended
February 28,
2015
|
|||||||||||||
Sales
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
||||||||
Cost of sales (1)
|
35.3
|
38.3
|
35.9
|
37.9
|
||||||||||||
Selling and administrative
|
36.5
|
39.6
|
36.6
|
38.2
|
||||||||||||
Net research and development
|
19.0
|
20.6
|
18.5
|
20.6
|
||||||||||||
Depreciation of property, plant and equipment
|
1.7
|
2.5
|
1.7
|
2.3
|
||||||||||||
Amortization of intangible assets
|
0.5
|
2.0
|
0.5
|
2.0
|
||||||||||||
Interest and other income
|
(0.9
|
)
|
(0.1
|
)
|
(0.4
|
)
|
(0.2
|
)
|
||||||||
Foreign exchange gain
|
(2.0
|
)
|
(5.9
|
)
|
(1.3
|
)
|
(4.6
|
)
|
||||||||
Earnings before income taxes
|
9.9
|
3.0
|
8.5
|
3.8
|
||||||||||||
Income taxes
|
2.5
|
1.2
|
3.2
|
1.6
|
||||||||||||
Net earnings for the period
|
7.4
|
%
|
1.8
|
%
|
5.3
|
%
|
2.2
|
%
|
||||||||
Other selected information:
|
||||||||||||||||
Gross margin before depreciation and amortization (2)
|
64.7
|
%
|
61.7
|
%
|
64.1
|
%
|
62.1
|
%
|
||||||||
Research and development:
|
||||||||||||||||
Gross research and development
|
21.4
|
%
|
23.9
|
%
|
20.9
|
%
|
23.7
|
%
|
||||||||
Net research and development
|
19.0
|
%
|
20.6
|
%
|
18.5
|
%
|
20.6
|
%
|
||||||||
Adjusted EBITDA (2)
|
9.9
|
%
|
2.3
|
%
|
9.7
|
%
|
4.0
|
%
|
(1)
|
The cost of sales is exclusive of depreciation and amortization, shown separately.
|
(2)
|
Refer to page 34 for non-IFRS measures.
|
Three months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 29,
2016
|
Six months
ended
February 28,
2015
|
|||||||||||||
Physical-layer product line
|
$
|
32,582
|
$
|
33,059
|
$
|
70,059
|
$
|
70,907
|
||||||||
Protocol-layer product line
|
21,990
|
18,531
|
40,619
|
37,699
|
||||||||||||
54,572
|
51,590
|
110,678
|
108,606
|
|||||||||||||
Foreign exchange losses on forward exchange contracts
|
(975
|
)
|
(600
|
)
|
(1,849
|
)
|
(892
|
)
|
||||||||
Total sales
|
$
|
53,597
|
$
|
50,990
|
$
|
108,829
|
$
|
107,714
|
Three months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 29,
2016
|
Six months
ended
February 28,
2015
|
|||||||||||||
Physical-layer product line
|
$
|
34,874
|
$
|
33,223
|
$
|
73,752
|
$
|
70,617
|
||||||||
Protocol-layer product line
|
25,804
|
22,027
|
46,273
|
39,169
|
||||||||||||
60,678
|
55,250
|
120,025
|
109,786
|
|||||||||||||
Foreign exchange losses on forward exchange contracts
|
(975
|
)
|
(600
|
)
|
(1,849
|
)
|
(892
|
)
|
||||||||
Total bookings
|
$
|
59,703
|
$
|
54,650
|
$
|
118,176
|
$
|
108,894
|
Three months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 29,
2016
|
Six months
ended
February 28,
2015
|
|||||||||||||
Americas
|
49
|
%
|
53
|
%
|
52
|
%
|
51
|
%
|
||||||||
EMEA
|
29
|
25
|
27
|
28
|
||||||||||||
Asia-Pacific
|
22
|
22
|
21
|
21
|
||||||||||||
100
|
%
|
100
|
%
|
100
|
%
|
100
|
%
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual
forward rates
|
||||||
March 2016 to August 2016
|
$
|
12,600,000
|
1.1976
|
|||||
September 2016 to August 2017
|
19,800,000
|
1.2779
|
||||||
September 2017 to August 2018
|
9,300,000
|
1.3402
|
||||||
September 2018 to December 2018
|
1,900,000
|
1.3639
|
||||||
Total
|
$
|
43,600,000
|
1.2717
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual
forward rates
|
||||||
March 2016 to August 2016
|
$
|
3,100,000
|
67.92
|
|||||
September 2016 to February 2017
|
1,400,000
|
71.12
|
||||||
$
|
4,500,000
|
68.91
|
Three months
ended
February 29,
2016
|
Three months
ended
February 28,
2015
|
Six months
ended
February 29,
2016
|
Six months
ended
February 28,
2015
|
|||||||||||||
IFRS net earnings for the period
|
$
|
3,963
|
$
|
931
|
$
|
5,729
|
$
|
2,412
|
||||||||
Add (deduct):
|
||||||||||||||||
Depreciation of property, plant and equipment
|
924
|
1,256
|
1,899
|
2,501
|
||||||||||||
Amortization of intangible assets
|
286
|
1,019
|
586
|
2,117
|
||||||||||||
Interest and other income
|
(470
|
)
|
(35
|
)
|
(407
|
)
|
(252
|
)
|
||||||||
Income taxes
|
1,364
|
586
|
3,480
|
1,751
|
||||||||||||
Stock-based compensation costs
|
314
|
388
|
690
|
788
|
||||||||||||
Foreign exchange gain
|
(1,101
|
)
|
(2,987
|
)
|
(1,411
|
)
|
(4,962
|
)
|
||||||||
Adjusted EBITDA for the period
|
$
|
5,280
|
$
|
1,158
|
$
|
10,566
|
$
|
4,355
|
||||||||
Adjusted EBITDA in percentage of sales
|
9.9%
|
|
2.3%
|
|
9.7%
|
|
4.0%
|
|
Quarters ended
|
||||||||||||||||
February 29,
2016
|
November 30,
2015
|
August 31,
2015
|
May 31,
2015
|
|||||||||||||
Sales
|
$
|
53,597
|
$
|
55,232
|
$
|
56,594
|
$
|
57,781
|
||||||||
Cost of sales (1)
|
$
|
18,904
|
$
|
20,137
|
$
|
21,975
|
$
|
22,281
|
||||||||
Net earnings
|
$
|
3,963
|
$
|
1,766
|
$
|
2,323
|
$
|
563
|
||||||||
Basic and diluted net earnings per share
|
$
|
0.07
|
$
|
0.03
|
$
|
0.04
|
$
|
0.01
|
Quarters ended
|
||||||||||||||||
February 28,
2015
|
November 30,
2014
|
August 31,
2014
|
May 31,
2014
|
|||||||||||||
Sales
|
$
|
50,990
|
$
|
56,724
|
$
|
59,742
|
$
|
63,882
|
||||||||
Cost of sales (1)
|
$
|
19,546
|
$
|
21,237
|
$
|
22,109
|
$
|
23,469
|
||||||||
Net earnings
|
$
|
931
|
$
|
1,481
|
$
|
1,204
|
$
|
1,665
|
||||||||
Basic and diluted net earnings per share
|
$
|
0.02
|
$
|
0.02
|
$
|
0.02
|
$
|
0.03
|
(1)
|
The cost of sales is exclusive of depreciation and amortization.
|